Sphingosine-1-phosphate receptor agonists

Details for Australian Patent Application No. 2010279354 (hide)

Owner Bristol-Myers Squibb Company

Inventors Gilmore, John L.; Sheppeck, James E.

Agent A J Park

Pub. Number AU-A-2010279354

PCT Pub. Number WO2011/017578

Priority 61/232,054 07.08.09 US

Filing date 6 August 2010

Wipo publication date 10 February 2011

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/454 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

9 February 2012 PCT application entered the National Phase

  PCT publication WO2011/017578 Priority application(s): WO2011/017578

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010279358-Functionally graded polycrystalline diamond insert

2010279337-Bicyclic aryl sphingosine 1-phosphate analogs